Psilocybin / Psychedelics generally are schedule I which is described as

The drug or other substance has no currently accepted medical use in treatment in the United States.

However, NIH, our own National Institutes of Health, either oversaw or published peer-reviewed studies demonstrating medical merit of nearly ALL psychedelics, but these psychedelics remain as Schedule 1 per the UN's convention on psychotropic substances which informs our laws and those of other countries. Given the compelling national dialogue regarding failed promises of pharmaceutical companies pushing psychiatric medications such as antidepressants that have been demonstrated to perform no better than placebo, the questions of 'how to deal with mental illnesses', 'how to fix spiritual disorders' will force us into another national dialogue of how to deal with the psychedelics such as mushrooms that are increasingly revealing themselves to be superior medications for these disorders.

In other words, mushrooms are medicine, so why are they not immediately removed from the DEA schedule? And what can we do about it? (one possible answer below)

Here are the studies:

• Magic mushrooms' effects illuminated in brain imaging studies -- Treats Depression
• Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. -- Treats Anxiety
• Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning. -- Stimulates neurogenesis and treats PTSD
• Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. -- treats OCD
• Response of cluster headache to psilocybin and LSD. -- Treats Cluster Headaches
• Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. -- makes people more open minded and spiritual; 'Positive changes in attitudes' -- makes people kinder.
• Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
• Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later -- Over a year later psilocybin users report use as meaningful, positive attitudes persist after 14mo
• Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
• Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin.
• Magic mushrooms' effects illuminated in brain imaging studies
• Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
• Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
• Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.

It is time to federally decriminalize psilocybin mushrooms. But we need the UN to retract the mushrooms from the 1971 Convention on Psychotropic substances. Until then, the DEA may not be able to^[1][2], unless it wants to defy the archaic and discriminatory drug convention the US helped craft, making the UN look weak.

Forum spies are welcome to come up with fracture points like this nsafag's in the original post. I mean, if you didn't, how else will we know you care and are listening to us? With that I leave you to it.